A strategic partnership between dominant cannabis track-and-trace providers Metrc and BioTrack could consolidate control over government compliance software nationwide. Announced earlier this week, the deal creates a new entity for BioTrack's public-sector operations amid sparse details that have halted New York's long-delayed implementation of seed-to-sale tracking. State regulators and operators now face uncertainty in markets worth billions.
Structure of the Partnership
The agreement establishes BT Government, an independent entity that assumes BioTrack's government-facing operations separate from both Metrc and BioTrack. BioTrack Chief Operating Officer Moe Afaneh will lead this new firm, while BioTrack retains its point-of-sale and commercial software services. Terms remain undisclosed, fueling speculation about deeper integration given Metrc's Florida base in Lakeland and BioTrack's in Fort Lauderdale.
Market Dominance and Competitive History
Metrc holds contracts in 29 states, requiring licensed operators to use its RFID-tagged software to monitor cannabis from seed to sale and prevent diversion to illicit markets. BioTrack serves eight states including Arkansas, Connecticut, Delaware, Hawaii, Florida, New York, New Mexico, North Dakota, and Virginia, but has lost ground recently—Illinois switched to Metrc in February, and Massachusetts renewed with the leader. BioTrack resulted from a 2018 merger with Helix TCS and a 2023 sale by Forian to Alleaves for $30 million.
Immediate Disruptions and Operator Concerns
New York suspended its track-and-trace deadline days after the announcement, citing the need to assess system impacts in a market exceeding $1.5 billion without prior monitoring. Operators there faced BioTrack mandates for tags on individual pre-rolls at 10 cents each—a requirement critics say exceeds state law and inflates costs—while Metrc's California contract totals $113 million over four years. Connecticut operators also await clarity, as cannabis businesses speculate Metrc software might supplant BioTrack contracts, potentially easing multistate operations but raising questions on timelines, pricing, and labor efficiencies.
Path Toward Unified Regulation
The partnership addresses the patchwork of state systems that burdens multistate operators, as noted by Poseidon Asset Management's Emily Paxhia, who sees potential for streamlined experiences as the $32 billion industry matures. A Metrc spokesperson emphasized enhanced transparency and public safety. While operators in Metrc states see minimal change, BioTrack markets brace for transition, marking a possible end to fragmented tracking in legal cannabis supply chains.
